However, at nearly non-toxic concentration, gedatolisib could not significantly reverse ABCB1- or ABCG2-medaited MDR in colorectal cancer cells, indicated that gedatolisib could not be a good reversal agent due to its relative high toxicity. The gene discussed is ABCG2; the disease is colorectal cancer.